Originally incubated and launched at Providence St. Joseph Health in 2017, Xealth, a Seattle company that has created a digital prescribing platform, has raised $11 million in a Series A financing round.
New investors McKesson Ventures, Novartis, Philips and ResMed join existing investors Threshold Ventures, Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin Health Network.
Xealth says its platform enables clinicians to prescribe and monitor digital health care content, apps, devices and services from within their electronic health record (EHR) charting interface, and to integrate the interaction into a health system's existing patient portal. These capabilities enable the delivery and measurement of digital care solutions to improve patient care.
Xealth works with UPMC; the Froedtert and the Medical College of Wisconsin health network; Baylor Scott and White; Duke and other health systems. More than 30 digital health solutions and over a million patient interactions are being prescribed and monitored by these partners
"With these new partners joining our existing investors and customers, Xealth will be serving virtually every sector of the health care industry—providers, payors, pharma, devices and supply chain," said Mike McSherry, chief executive officer of Xealth, in a prepared statement. "The Xealth platform is quickly becoming the preferred 'digital formulary.'"
